Correlation between thromboelastography and traditional coagulation test parameters in hospitalized dogs

No prior work had resolved whether advanced clotting assessments provide identical information to conventional laboratory panels in canine patients. That uncertainty drove clinicians to rely on disparate diagnostic tools without knowing if they reflect the same physiological processes. Prior research has shown that standard coagulation assays measure specific clotting factors rather than global clot formation dynamics. This gap motivated the need to evaluate how these distinct diagnostic approaches relate within a clinical setting. It was already known that thromboelastography offers a functional view of hemostasis, yet its relationship to traditional markers remained poorly defined in sick animals. That ambiguity hindered the development of standardized monitoring protocols for intensive care units. Researchers required a direct comparison to determine if these tests offer redundant or complementary data. This study addresses the lack of evidence regarding the consistency of these diagnostic modalities in a hospital population.

The study aimed to determine the relationship between kaolin-activated thromboelastography and traditional coagulation tests in a cohort of hospitalized dogs. This investigation addressed the uncertainty regarding whether functional clot analysis provides information equivalent to standard laboratory panels. Clinicians frequently use both methods, yet the degree of overlap between them remains poorly understood in veterinary practice. That ambiguity motivated the researchers to quantify the correlation between these distinct diagnostic approaches. The team sought to clarify if one test could serve as a proxy for the other when monitoring patients. By comparing these markers, the authors intended to evaluate the clinical utility of functional testing in an intensive care environment. No prior work had resolved the consistency of these measurements within this specific patient population. This research provides a necessary assessment to guide diagnostic selection for veterinarians managing complex clotting disorders.

The investigators conducted a prospective cross-sectional study involving 29 hospitalized dogs requiring coagulation assessment. Review approach involved collecting blood samples from each subject to perform both functional and standard laboratory assays. The team measured prothrombin time, partial thromboplastin time, antithrombin activity, d-dimer concentration, and fibrinogen levels. Simultaneously, they utilized kaolin-activated thromboelastography to evaluate global clot formation dynamics. Hematocrit levels were also recorded to provide a comprehensive view of the patient's blood profile. Statistical evaluation relied on Spearman's correlation to determine the relationship between the two distinct testing methodologies. The researchers compared the results from the functional analysis against the conventional laboratory markers. This systematic approach ensured that all data points were derived from the same clinical population to maintain consistency.

The strongest finding indicates that fibrinogen levels positively correlate with maximum amplitude and global clot strength. The statistical analysis revealed a Pearson r value of 0.72 with a p-value below 0.001 for these specific associations. Conversely, no significant correlation existed between any other traditional coagulation variables and the functional test parameters. Furthermore, hematocrit levels showed no relationship with the results obtained from the thromboelastography analysis. The data demonstrate that standard coagulation tests and functional clot assessments provide distinct information. These findings suggest that the two methods do not measure the same aspects of hemostasis in this patient group. The lack of correlation across most variables highlights the divergence between protein-based assays and functional clot analysis. Consequently, the study confirms that these diagnostic tools offer non-redundant insights into the clotting status of hospitalized dogs.

The authors propose that these two diagnostic modalities are not interchangeable for tracking clotting abnormalities in hospitalized animals. This synthesis suggests that clinicians should interpret results from each test independently rather than assuming they reflect identical hemostatic states. The researchers emphasize that standard coagulation assays and functional clot analysis provide unique, non-overlapping information. No evidence supports using one method as a direct substitute for the other in clinical practice. The authors note that future work must identify a definitive outcome measure to validate the clinical utility of this functional test. This implication highlights the current limitation in applying such advanced diagnostics to veterinary care without further outcome-based evidence. The findings demonstrate that relying on one test to predict the other is inappropriate given the observed lack of correlation. Ultimately, the study underscores the complexity of monitoring hemostasis in critically ill patients.